Clinical Trial Update: Levofloxacin In The Treatment Of Children With Recurrent And/or Persistent Acute Otitis Media [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating levofloxacin for recurrent and/or persistent acute otitis media in children has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Otitis Media

Drugs mentioned

• Levofloxacin (Levofloxacin)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Otitis Media | Phase 3 | Status: COMPLETED